ALB vs LBRX · rev $1.74B vs $803.4M cap
Albemarle Corp (ALB) versus LB Pharmaceuticals Inc Common Stock (LBRX) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
LB Pharmaceuticals Inc Common Stock (LBRX) is a biotechnology company listed on NASDAQ.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
LBRX does not have a complete income-statement cache yet.
ALB currently screens at market cap $8.00B. LBRX currently screens at market cap $803.4M.
Not investment advice. Open the ALB and LBRX stock pages for the full models.
Not investment advice.